Skip to content

The evaluation of canola protein and whey protein to support muscle conditioning in vivo in young females

The evaluation of canola protein and whey protein to support muscle conditioning in vivo in young females - ALPACA study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51718
Enrollment
50
Registered
2022-09-29
Start date
2023-03-20
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle anabolism Muscle growth

Interventions

20g Whey protein, 20g canola protein, or non-caloric placebo drink Strength exercise

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Female sex • Age between 18 and 35 y inclusive • BMI between 18.5 and 30 kg/m2 • Having given informed consent

Exclusion criteria

Exclusion criteria: • Intolerant to milk products • Mustard allergy • Participating in a structured (progressive) exercise program • Smoking regularly • Diagnosed GI tract disorders or diseases • Diagnosed musculoskeletal disorders • Diagnosed metabolic disorders (e.g. diabetes) • Hypertension (blood pressure above 140/90 mmHg) • Donated blood 3 months prior to test day • Pregnant • Using third generation oral contraceptives • Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories). • Chronic use of gastric acid suppressing medication • Chronic use of anti-coagulants • Recent (

Design outcomes

Primary

MeasureTime frame
Postprandial muscle protein synthesis rates (0-5h)

Secondary

MeasureTime frame
Basal muscle protein synthesis rates Plasma glucose, insulin, amino acids + corresponding peak values and (i)AUC Plasma 13C6-phe enrichments Muscle signalling pathways

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)